Capdevila, J, Paez, D, Villacampa, MM, Garcia-Alvarez, A, Aparicio, J, Pampols, M, Riesco-Martinez, MD, Polo, E, Ruiz-Casado, A, Castañon, C, Soriano, S, Hernando, J, Navalpotro, B, Armario, D, Villacampa, G, Horvath, E, Virgili, AC, Asiain, L, Giménez, A, Guillot, M. Atezolizumab plus tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal: TIRANUS (GEMCAD-2103) trial.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(2_SUPPL)DOI:10.1200/JCO.2026.44.2_suppl.11. PMID:. IF:41.900(Q1/1D).

Hayes, M, Nakajima, TE, Seecof, O, Majem, M, Chenji, S, Ashki, N, Ceccarelli, M, Van Cutsem, E. A phase 2 randomized, double-blind, placebo-controlled study to evaluate LY3537021 for the treatment of chemotherapy-induced nausea and vomiting in patients with malignant disease.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(2_SUPPL)DOI:10.1200/JCO.2026.44.2_suppl.TPS855. PMID:. IF:41.900(Q1/1D).

Martín, AJM, Castet, F, Vera, R, Alvarez, R, Garcia-Alfonso, P, Alsar, JS, Palao, P, Diaz, IA, Vidal-Tocino, R, Adeva, J, Modrego, A, Maseda, AC, Martínez-Galán, J, Serda, PC, Rodriguez-Alonso, RM, Aranda, E, La Casta, A, de Castro, EM, Montes, AFF, Macarulla, T. Isocitrate dehydrogenase 1 mutations in biliary tract cancer patients in Spanish RETUD registry. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(2_SUPPL)DOI:10.1200/JCO.2026.44.2_suppl.500. PMID:. IF:41.900(Q1/1D).

Martín, AJM, Castet, F, Vera, R, Alvarez, R, Pertusa, C, Garcia-Alfonso, P, Rodríguez, RJ, Vidal-Tocino, R, Diaz, IA, Caro, NL, Adeva, J, Paladines, WGP, Maseda, AC, Rodriguez-Alonso, RM, Aranda, E, Serda, PC, de Castro, EM, La Casta, A, Laquente, B, Macarulla, T. ERBB2/HER2 status in biliary tract cancer patients in the Spanish RETUD registry.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(2_SUPPL)DOI:10.1200/JCO.2026.44.2_suppl.498. PMID:. IF:41.900(Q1/1D).

Alonso-Gordoa, T, Anguera, G, Domínguez-Esteban, M, Reig, O, Martínez-Barros, H, Molina-Cerrillo, J, Cruz, P, Maroto, P. Expert consensus on patterns of progression in kidney cancer after adjuvant immunotherapy and subsequent treatment strategies. CANCER TREATMENT REVIEWS. 2025; 136DOI:10.1016/j.ctrv.2025.102925. PMID:40186886. IF:10.500(Q1/1D).

Favaro, MTP, Alamo, P, Roher, N, Chillon, M, Lascorz, J, Márquez, M, Corchero, JL, Mendoza, R, Martínez-Torró, C, Ferrer-Miralles, N, Ferreira, LCS, Mangues, R, Vázquez, E, Parladé, E, Villaverde, A. Zinc-Assisted Microscale Granules Made of the SARS-CoV-2 Spike Protein Trigger Neutralizing, Antivirus Antibody Responses. ACS Materials Letters. 2024; 6(3)DOI:10.1021/acsmaterialslett.3c01643. PMID:. IF:8.700(Q1/2D).

Vergouwen, MDI, Ramos-Pachon, A, Terecoasa, EO, Willett, N, Cuadrado-Godia, E, Gaberel, T, Gizewski, ER, Helbok, R, Ho, LA, Hugelshofer, M, Korja, M, Meling, TR, Psychogios, MN, Rinkel, GJE, Taschner, CA, Vajkoczy, P, Etminan, N. European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage. European Stroke Journal. 2026; 11(5)DOI:10.1093/esj/aakag043. PMID:42095754. IF:4.500(Q1/2D).

Lambea-Gil, A, Camps-Renom, P, Martí-Fàbregas, J, Guasch-Jiménez, M, Ezcurra-Díaz, G, Fernández-Vidal, JM, Prats-Sanchez, L, Martínez-Domeño, A, de la Ossa, NP, Ramos-Pachón, A. Early care limitation after ICH in a population-based study: what drives clinicians' decisions?. European Stroke Journal. 2026; 11(4)DOI:10.1093/esj/aakag028. PMID:41947561. IF:4.500(Q1/2D).

van Kleef, ESB, Bouman, K, Molenaar, JPF, Küsters, B, Groothuis, JT, Olivé, M, Malfatti, E, Kamsteeg, EJ, Van Engelen, BGM, Ottenheijm, CAC, Doorduin, J, Voermans, NC. Nemaline Myopathy Type 6 Caused by Variants in the KBTBD13 Gene. Neurology-Genetics. 2024; 10(6)DOI:10.1212/NXG.0000000000200214. PMID:39651462. IF:3.700(Q1/3D).

Dominguez-González, C, Romero, MAB, Eraso, CC, de las Heras, J, Muñoz, EF, Garcia-Campos, O, González, M, Grau, JM, Hernández-Voth, A, Morales, RJ, Hernández, JCL, Martos, ML, López-Padilla, D, Muelas, N, Nascimento, A, Olivé, M, Paradas, C, Fernández, JP, Pascual, SI, Pitarch, I, Sancho, J, Diaz-Manera, J. Recommendations for the diagnostic, treatment, and follow-up of late-onset Pompe disease. NEUROLOGIA. 2026; 41(2)DOI:10.1016/j.nrl.2025.501933. PMID:41453611. IF:3.100(Q2/4D).

Torchia, E, Lucchini, M, Verdu-Diaz, J, Bortolani, S, Ravera, B, Carlomagno, V, Cicia, A, Bernardo, D, Monforte, M, Rehmann, R, Kley, RA, Sabatelli, M, Díaz-Manera, J, Ricci, E, Mirabella, M, Tasca, G. Muscle Imaging in Inclusion Body Myositis: Refinement of MRI Criteria and Insights Into Upper Body Involvement. Journal of Cachexia Sarcopenia and Muscle. 2026; 17(1)DOI:10.1002/jcsm.70173. PMID:41549703. IF:9.100(Q1/1D).

Doneddu, PE, Collet-Vidiella, R, Gallo, C, Cocito, D, Manganelli, F, Falzone, Y, Dalla Bella, E, Benedetti, L, Mazzeo, A, Peci, E, Spina, E, Strano, C, Germano, F, Gentile, L, Liberatore, G, Cutellè, C, Bianchi, E, Querol, L, Nobile-Orazio, E. Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized Trial. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2026; 31(1)DOI:10.1111/jns.70107. PMID:41649095. IF:3.200(Q2/4D).

De Pedro, S, Presa, M, Gamez, J, Fernández, FJG, Querol, L. Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain. Pharmacoeconomics-Open. 2026; 10(2)DOI:10.1007/s41669-025-00633-8. PMID:41528376. IF:(Q/D).

Costas-Carrera, A, Verdolini, N, Garcia-Rizo, C, Mezquida, G, Janssen, J, Valli, I, Corripio, I, Sanchez-Torres, AM, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Rapado-Castro, M, Vieta, E, de la Serna, H, Mane, A, Roldan, A, Crossley, N, Penades, R, Cuesta, MJ, Parellada, M, Bernardo, M. Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis. PSYCHOLOGICAL MEDICINE. 2024; DOI:10.1017/S0033291723003185. PMID:38014924. IF:5.500(Q1/1D).

Argyelan M, Deng ZD, Ousdal OT, Oltedal L, Angulo B, Baradits M, Spitzberg AJ, Kessler U, Sartorius A, Dols A, Narr KL, Espinoza R, van Waarde JA, Tendolkar I, van Eijndhoven P, van Wingen GA, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Paulson OB, Yrondi A, Péran P, Soriano-Mas C, Cardoner N, Cano M, van Diermen L, Schrijvers D, Belge JB, Emsell L, Bouckaert F, Vandenbulcke M, Kiebs M, Hurlemann R, Mulders PC, Redlich R, Dannlowski U, Kavakbasi E, Kritzer MD, Ellard KK, Camprodon JA, Petrides G, Malhotra AK, Abbott CC. Correction: Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.. MOLECULAR PSYCHIATRY. 2024; 29(2)DOI:10.1038/s41380-023-02358-8. PMID:38052984. IF:(Q/D).

Saura, J, Feliu, A, Enriquez-Mestre, M, Fu, M, Ballbe, M, Castellano, Y, Pla, M, Rosa, N, Radeva, P, Maestre-Gonzalez, E, Cabezas, C, Colom, J, Suelves, JM, Mondon, S, Barrio, P, Andreu, M, Raich, A, Bernabeu, J, Vilaplana, J, Tutusaus, XR, Guydish, J, Fernandez, E, Martinez, C. Patterns of Use and Withdrawal Syndrome in Dual Cannabis andTobacco Users (DuCATA_GAM-CAT):Protocol for a MixedMethods Study. Jmir Research Protocols. 2024; 13DOI:10.2196/58335. PMID:39298750. IF:(Q/D).

Pegueroles, J, Montal, V, Bejanin, A, Vilaplana, E, Aranha, M, Santos-Santos, MA, Alcolea, D, Carrio, I, Camacho, V, Blesa, R, Lleo, A, Fortea, J. AMYQ: An index to standardize quantitative amyloid load across PET tracers. ALZHEIMERS & DEMENTIA. 2021; 17(9)DOI:10.1002/alz.12317. PMID:33797846. IF:16.655(Q1/1D).

Abras, A, Ballart, C, Fernández-Arévalo, A, Llovet, T, Gállego, M, Muñoz, C. Assessment of Alinity s Chagas® as a Primary Diagnostic Test for Chronic Chagas Disease in a Non-Endemic Area of Europe (Barcelona, Spain). Life-Basel. 2024; 14(10)DOI:10.3390/life14101278. PMID:39459578. IF:3.400(Q1/3D).

Salamanca-Rivera, E, Palacios-Baena, ZR, Cañada, JE, Moure, Z, Pérez-Vázquez, M, Calvo-Montes, J, Martínez-Martínez, L, Cantón, R, Carrascoso, GR, Pitart, C, Navarro, F, Bou, G, Mulet, X, González-López, JJ, Sivianes, F, Delgado-Valverde, M, Pascual, A, Oteo-Iglesias, J, Rodríguez-Baño, J. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain. INFECTION. 2024; DOI:10.1007/s15010-024-02267-0. PMID:38703288. IF:3.600(Q2/3D).

Agarwal, N, Castellano, D, Alonso-Gordoa, T, Arija, JAA, Colomba, E, Gravis, G, Mourey, L, Oudard, S, Fléchon, A, González, M, Rey, PM, Schweizer, MT, Gallardo, E, Johnston, E, Balar, A, Haddad, N, Appiah, AK, Nacerddine, K, Piulats, JM. A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1. CLINICAL CANCER RESEARCH. 2024; 30(11)DOI:10.1158/1078-0432.CCR-23-3436. PMID:38512117. IF:10.200(Q1/1D).